Granahan Investment Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-443,120
Closed -$1.05M 247
2016
Q2
$1.05M Sell
443,120
-226,830
-34% -$626K 0.04% 203
2016
Q1
$2.16M Sell
669,950
-70,680
-10% -$261K 0.08% 191
2015
Q4
$3.55M Buy
740,630
+341,065
+85% +$1.93M 0.12% 189
2015
Q3
$2.22M Buy
399,565
+188,000
+89% +$1.39M 0.07% 219
2015
Q2
$1.68M Buy
211,565
+74,640
+55% +$641K 0.05% 223
2015
Q1
$1.44M Sell
136,925
-4,440
-3% -$60.7K 0.04% 221
2014
Q4
$1.7M Sell
141,365
-163,548
-54% -$2.49M 0.05% 195
2014
Q3
$5.21M Sell
304,913
-229,047
-43% -$3.32M 0.16% 160
2014
Q2
$6.45M Sell
533,960
-96,140
-15% -$911K 0.19% 152
2014
Q1
$5.32M Buy
630,100
+122,849
+24% +$991K 0.14% 174
2013
Q4
$2.99M Buy
+507,251
New +$2.61M 0.08% 187

Other funds holding BDSI

Granahan Investment Management's BDSI Position: Q3 2016 in Review

Granahan Investment Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q3 2016, closing a stake of 443,120 shares — an estimated $1.05M sold.

Granahan Investment Management first reported a position in BDSI in Q4 2013 and held it in 11 quarters. The position peaked at $6.45M in Q2 2014. 85 funds tracked by Wall St. Rank hold BDSI as of Q3 2016.

  • Granahan Investment Management reported no remaining BioDelivery Sciences International, Inc. position as of Q3 2016 after selling out during the quarter.
  • Granahan Investment Management sold 443,120 BioDelivery Sciences International, Inc. shares in Q3 2016, an estimated $1.05M.
  • Granahan Investment Management first reported a position in BioDelivery Sciences International, Inc. in Q4 2013 and held it in 11 quarters.
  • Granahan Investment Management's BioDelivery Sciences International, Inc. position peaked at $6.45M in Q2 2014.
  • 85 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q3 2016.

Based on Granahan Investment Management's 13F filing for Q3 2016, filed 14 Nov 2016.